258 related articles for article (PubMed ID: 15953942)
21. [Primary prevention of sudden cardiac death implanted cardioverter defibrillator (ICD) versus antiarrhythmic drugs].
Iturralde Torres P
Arch Cardiol Mex; 2007; 77 Suppl 4():S4-129-32. PubMed ID: 18938711
[TBL] [Abstract][Full Text] [Related]
22. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
Ding L; Hua W; Niu H; Chen K; Zhang S
Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335
[TBL] [Abstract][Full Text] [Related]
23. Implantable cardioverter-defibrillators in children.
Werner B; Przybylski A; Kucińska B; Lewandowski M; Szwed H; Wróblewska-Kałuzewska M
Kardiol Pol; 2004 Mar; 60(3):239-46. PubMed ID: 15156219
[TBL] [Abstract][Full Text] [Related]
24. Early therapy following myocardial infarction: arguments for and against implantable cardioverter-defibrillators.
Sredniawa B; Mazurek M; Lenarczyk R; Kowalski O; Kowalczyk J; Kalarus Z
Future Cardiol; 2010 May; 6(3):315-23. PubMed ID: 20462338
[TBL] [Abstract][Full Text] [Related]
25. AICD treatment in 2004--state of the art.
Budde T
Eur J Med Res; 2006 Oct; 11(10):432-8. PubMed ID: 17107877
[TBL] [Abstract][Full Text] [Related]
26. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.
Healey JS; Hallstrom AP; Kuck KH; Nair G; Schron EP; Roberts RS; Morillo CA; Connolly SJ
Eur Heart J; 2007 Jul; 28(14):1746-9. PubMed ID: 17283003
[TBL] [Abstract][Full Text] [Related]
27. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
[TBL] [Abstract][Full Text] [Related]
28. Implantable cardioverter defibrillator therapy for patients with less severe left ventricular dysfunction.
Exner DV
Curr Opin Cardiol; 2009 Jan; 24(1):61-7. PubMed ID: 19077818
[TBL] [Abstract][Full Text] [Related]
29. Prevention of sudden cardiac death.
Goldberger JJ
Heart Dis; 2000; 2(4):305-13. PubMed ID: 11728274
[TBL] [Abstract][Full Text] [Related]
30. [Defibrillators--end of sudden cardiac death?].
Kozák M
Vnitr Lek; 2004 Oct; 50 Suppl 1():S63-7. PubMed ID: 15651143
[TBL] [Abstract][Full Text] [Related]
31. Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction.
Goldenberg I; Moss AJ; McNitt S; Zareba W; Andrews ML; Hall WJ; Greenberg H; Case RB;
Am J Cardiol; 2006 Aug; 98(4):485-90. PubMed ID: 16893702
[TBL] [Abstract][Full Text] [Related]
32. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death.
Cuculich PS; Sánchez JM; Kerzner R; Greenberg SL; Sengupta J; Chen J; Faddis MN; Gleva MJ; Smith TW; Lindsay BD
Pacing Clin Electrophysiol; 2007 Feb; 30(2):207-13. PubMed ID: 17338717
[TBL] [Abstract][Full Text] [Related]
33. Preventing sudden death: implantable cardioverter-defibrillators in elderly cardiac patients.
Groeneveld PW
LDI Issue Brief; 2008; 13(6):1-4. PubMed ID: 18613344
[TBL] [Abstract][Full Text] [Related]
34. [The implantable cardioverter-defibrillator: sometimes necessary].
Smeets JL
Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2113-5. PubMed ID: 15553353
[TBL] [Abstract][Full Text] [Related]
35. The incidence of implantable cardioverter defibrillator indications in patients admitted to all coronary care units in a single district.
Plummer CJ; John Irving R; McComb JM
Europace; 2005 May; 7(3):266-72. PubMed ID: 15878566
[TBL] [Abstract][Full Text] [Related]
36. [How many leads are needed for an ICD?].
Schaumann A; Gödde M; Tönnis T
Herz; 2005 Nov; 30(7):591-5. PubMed ID: 16333583
[TBL] [Abstract][Full Text] [Related]
37. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.
Goldenberg I; Vyas AK; Hall WJ; Moss AJ; Wang H; He H; Zareba W; McNitt S; Andrews ML;
J Am Coll Cardiol; 2008 Jan; 51(3):288-96. PubMed ID: 18206738
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of implantable cardioverter-defibrillators in patients with ischemic heart disease and left ventricular dysfunction.
Chan PS; Chow T; Kereiakes D; Schloss EJ; Waller T; Eagle K; Hayward RA; Vijan S
Arch Intern Med; 2006 Nov; 166(20):2228-33. PubMed ID: 17101941
[TBL] [Abstract][Full Text] [Related]
39. Sudden death prophylaxis in heart failure.
Rosanio S; Schwarz ER; Vitarelli A; Zarraga IG; Kunapuli S; Ware DL; Birnbaum Y; Tuero E; Uretsky BF
Int J Cardiol; 2007 Jul; 119(3):291-6. PubMed ID: 17208319
[TBL] [Abstract][Full Text] [Related]
40. Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population.
Cowie MR; Marshall D; Drummond M; Ferko N; Maschio M; Ekman M; de Roy L; Heidbuchel H; Verboven Y; Braunschweig F; Linde C; Boriani G
Europace; 2009 Jun; 11(6):716-26. PubMed ID: 19359333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
